Tyra Biosciences (NASDAQ:TYRA) Given Outperform Rating at Oppenheimer
Oppenheimer restated their outperform rating on shares of Tyra Biosciences (NASDAQ:TYRA – Free Report) in a research report report published on Monday, Benzinga reports. Oppenheimer currently has a $28.00 price target on the stock, up from their previous price target of $25.00. A number of other brokerages have also weighed in on TYRA. Wedbush restated […]
More Stories
Oasis Season 1 is Live on Netflix! Review, Rating, and Update on Season 2 Release
Netflix has released an all-new Spanish mystery thriller, Oasis, season 1. The series is full of thriller scenes and suspenseful...
Ricky Gervais’ Alley Cats Trailer is Out! Know the Release Date and Other Details
Ricky Gervais is coming back with an all-new adult animated series, Alley Cats. The theme is about the everyday life...
Better Late Than Single Season 2: Release Date, Contestants Details, Trailer, and More
Better Late Than Single is a South Korean reality show that first premiered on Netflix in July 2025. Better Late...
10 Best Animated Movies that You Can Binge-Watch on Netflix
Are you also an animation movie lover, just like me? Here, in this blog, I have mentioned some of the...
8 Best K-Dramas on Netflix for Beginners to Binge-Watch on the Weekend
Lots of Korean dramas, but confused about which one you should watch? Here, in this blog, I will share my...
Is Running Point Season 3 Coming? Release Date, Production Status, and Cast Members
Running Point is an American sports comedy series that first premiered in 2025 on Netflix. The must-watch comedy sports series...